Long-Acting Injectable Buprenorphine-XRBUP Training-Lummi Tribal Health-3.6.2024-Dr.Spencer

Video Transcription

Video Summary

The video discusses the implementation of long-acting injectable buprenorphine for patients with substance use disorders in a clinic setting. Dr. Lane, Dr. Ray, and the team are exploring the option of offering this treatment to patients to enhance medication monitoring and minimize withdrawal risks. Dr. Sarah Spencer's presentation highlights the benefits of long-acting injectable buprenorphine, particularly for patients facing challenges like medication continuity issues or stigma. The presentation also delves into the comparison between sublocate and Brixadi, covering dosing, administration techniques, and considerations for patient management. The training session underscores the importance of patient satisfaction, quality of life improvements, and proper administration techniques for optimal outcomes. The transcript of the video further outlines the process of administering the medication, potential challenges for non-medical staff, and the benefits of long-acting buprenorphine for patients struggling with ongoing drug use, especially fentanyl. Dosage adjustments, retention benefits of higher doses, and the efficacy of long-acting buprenorphine in tapering patients off sublingual buprenorphine are also discussed. A study comparing different doses of the medication suggests better treatment retention with higher doses for patients using injection drugs.

Keywords

long-acting injectable buprenorphine

substance use disorders

medication monitoring

withdrawal risks

patient satisfaction

administration techniques

dosing

patient management

quality of life improvements

tapering off sublingual buprenorphine